Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

黃加璋 (Chia-Chang Huang)

黃加璋(Chia-Chang Huang)圖 Return Appointment First Appointment

[Profile]

  • Education
    • 臺北醫學大學 醫學系 醫學士,
  • Career and Experience
    Current Positions：
    • - Now, 2013臺北榮民總醫院教學部主治醫師,
    Experiences：
    • - , 2010國立陽明大學兼任講師,
    • - , 2009臺北榮民總醫院教學研究部主治醫師,
    • - , 2008 臺北榮民總醫院高齡醫學中心研究醫師,
    • - , 2006 臺北榮民總醫院內科部內分泌暨新陳代謝科總醫師,
    • - , 2003臺北榮民總醫院內科部住院醫師(代訓),
  • Medical Expertise
    1. 一般內科、內分泌疾病
    2. 糖尿病、甲狀腺疾病
    3. 老年學暨老年醫學相關疾病
  • License
    內科 專科醫師 內分泌暨新陳代謝科 專科醫師 老年醫學專科醫師 一般科超音波專業醫師 臺北市糖尿病共同照護網糖尿病認證醫師

[Publications]

第一作者

  • Huang CC, Yeh HY, Lin R, Liao TL, Shen HC, Yang YY, Lin HC. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice. Am J Physiol Gastrointest Liver Physiol. 2024 Jan 22. [IF 3.9]

第一加通訊作者

  • Huang CC*, Yeh HY, Lin R, Liao TL, Shen HC, Yang YY, Lin HC. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice. Am J Physiol Gastrointest Liver Physiol. 2024 Apr 1. [IF 4.5]

共同作者

  • Yeh HY, Wu HH, Shen HC, Li TH, Yang YY, Lee KC, Lin YH, Huang CC, Hou MC. Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures. Endocr Connect. 2024 May 1. [IF 2.6]
  • Shen HC, Pan MH, Huang CJ, Yeh HY, Yang HI, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC. Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study. Gene. 2024 Jun 10. [IF 2.6]
  • Shen HC, Pan MH, Huang CJ, Yeh HY, Yang HI, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC. Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study. Gene. 2024 Nov 15. [IF 2.6]
  • Lin YH, Wang CH, Huang YH, Shen HC, Wu WK, Yeh HY, Huang CC, Su CW, Yang YY, Wu MS, Lin HC, Hou MC. Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients. Kaohsiung J Med Sci. 2024 Nov 4. [IF 2.7]
回到最上